26S Proteasome p48A Antibodies

Santa Cruz Biotechnology offers a broad range of 26S Proteasome p48A monoclonal antibodies for research in protein degradation and cellular regulation. 26S Proteasome p48A Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The 26S Proteasome p48A protein is a key component in the ubiquitin-proteasome pathway, maintaining cellular homeostasis through protein turnover regulation. 26S Proteasome p48A recognizes and processes ubiquitinated substrates, influencing cell cycle progression, apoptosis, and signal transduction. Research focused on 26S Proteasome p48A continues to reveal its significance in cellular function and disease mechanisms. Understanding 26S Proteasome p48A activity provides valuable insights into potential therapeutic approaches. Investigating the role of 26S Proteasome p48A advances knowledge in protein degradation pathways and cellular maintenance. Current studies highlight the importance of 26S Proteasome p48A in maintaining cellular health and preventing disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of protein degradation mechanisms and their impact on human health.